The U.S. Food and Drug Administration has approved the first replacement heart valve made from donated human tissue in which the cells have been removed.
Traditionally, when human tissue is recovered from a cadaver for future implantation, it is inspected, cleaned and decontaminated to prevent infection, but the allograft (human) product remains otherwise unchanged.
The FDA said CryoLife Inc. has added a manufacturing step to its CryoValve SynerGraft Pulmonary Valve and Valved-Conduit Allograft that removes the tissue's cells and cellular debris.
What remains is a scaffold of connective tissue that still functions like a human heart valve, potentially lowering the risk of an immune response and subsequent tissue rejection, the FDA said.
Allograft heart valves are popular choices for children because they avoid the need to take blood-thinning medications on a long-term basis, officials said, and are less likely to calcify than are heart valves from a pig or cow.
The FDA said the SynerGraft valve is for use in patients who require replacement of their pulmonary valve because of disease, malformation or malfunction of their own pulmonary valve, or as part of another surgical procedure.
CryoLife is based in Kennesaw, Ga.
Copyright 2008 by United Press International
Related stories:
Sounding out heart problems automatically
Sounding the chest with a cold stethoscope is probably one of the most commonly used diagnostics in the medical room after peering down the back of the throat while the patient says, "Aaaah". But, research published in the inaugural issue of the
International Journal of Medical Engineering and Informatics looks set to add an information-age approach to diagnosing heart problems. The technique could circumvent the problem of the failing stethoscope skills of medical graduates and reduce errors of judgment
Good dental hygiene may help prevent heart infection
Good dental hygiene and health may be crucial in preventing heart valve infection, according to research reported in
Circulation: Journal of the American Heart Association.
Web will work wonders for the faint hearted
A new device could put the beat back into weak hearts - and free patients from a lifetime of anti-rejection drugs.
Ultrasound upgrade produces images that work like 3-D movies
Parents-to-be might soon don 3-D glasses in the ultrasound lab to see their developing fetuses in the womb "in living 3-D, just like at the IMAX movies," according to researchers at Duke University's Pratt School of Engineering.
Engineering the heart piece by piece
Some day, heart attack survivors might have a patch of laboratory-grown muscle placed in their heart, to replace areas that died during their attack. Children born with defective heart valves might get new ones that can grow in place, rather than being replaced every few years. And people with clogged or weak blood vessels might get a new “natural” replacement, instead of a factory-made one.
Natural polyester makes new sutures stronger, safer
With the help of a new type of suture based on MIT research, patients who get stitches may never need to have them removed.
Students Build Smaller, Smarter Heart Pump
A miniaturized heart pump designed by a team of University of Florida engineering students could become a life-saving alternative for patients waiting in long lines for scarce donor hearts.
The UF team is creating a device with a novel pumping technology that makes it smaller and smarter than currently available ventricular assist devices, which are too large to be implanted in many patients. The pump’s small size means also it would be the first such device in the U.S. that could be used in children.
'Healthy' sterols may pose health risk
Plant sterols have been touted as an effective way to lower cholesterol and reduce the risk of heart disease. However, a research study in the July JLR has uncovered that these compounds do have their own risks, as they can accumulate in heart valves and lead to stenosis.